Xylem Inc.

Executive Summary

BUY, Medium conviction. XYL rates a BUY, Medium conviction. The stock has already absorbed a lot of bad news, with China down sharply and MCS deployment delays forcing a lower FY26 organic growth range, yet management still raised EPS guidance to $5.55-$5.70 and raised EBITDA margin guidance to 23.1%-23.5%. At $108.00, the setup favors forward earnings power over trailing optics, especially with $5.3B backlog, book-to-bill above 1, and Applied Water seeing data-center orders up over 300% in Q2.

Investment Thesis

XYL is being priced as if the growth slowdown is the main story. It is not. The important fact is that management cut FY26 organic growth to 2%-3% because of electric metering deployment delays, yet still raised EPS guidance to $5.55-$5.70 from $5.35-$5.60 and raised EBITDA margin guidance to 23.1%-23.5%. That combination matters more than the headline revenue trim. It says the portfolio is getting structurally better, with more productivity, better mix, and more resilient end markets than the market is crediting.

At $108.00, the stock trades at about 19x the midpoint of FY26 guidance. That is the number that matters, not the trailing 25.63x FY25 P/E. For a company with a $5.3B backlog, book-to-bill above 1, seven straight quarterly EPS beats, and balance-sheet leverage of only 1.71x debt/EBITDA, that forward valuation is not demanding. It is also below the 29.9x peer average P/E, even though XYL has a cleaner secular demand story than many industrial peers because water spending is tied to regulation, resilience, leakage reduction, quality compliance, and infrastructure modernization.

The second leg of the case is that the moat is improving. Historically XYL was easier to pigeonhole as a water equipment company. Today the story is broader: sensing, mobile treatment, network intelligence, and digital tools are becoming more central. TriOS and WaterFleet support that direction, and management continues to fold digital capabilities into MCS. AI is not a threat to that model. It should increase the value of sensor-rich, connected systems that help utilities and industrial users optimize water flow, treatment, and uptime. The same logic applies to data centers, where Applied Water orders were up over 300% in Q2.

The case depends on three things. First, MCS delays must convert into revenue rather than turn into cancellations. Second, China cannot keep getting worse from a base where sales were already down 27% and orders down over 30%. Third, free cash flow has to catch up to earnings, because $0.2B of FY25 FCF is too low for comfort after $0.7B of buybacks. Those are real issues, and they cap conviction at Medium. But with the stock down nearly 30% from the high while earnings power is moving up, the market has become too focused on the delays and not focused enough on what XYL is becoming.

Key Metrics

Financial Strength

The balance sheet is not the problem here. At 1.71x debt/EBITDA, 0.29 debt/equity, and a 1.61 current ratio, XYL has enough flexibility to manage through a soft patch in China and MCS while still investing in portfolio upgrades. Margin direction is the more important signal, and it is favorable: FY25 operating margin improved to 12.2% from 11.8%, and Q2 FY26 EBITDA margin reached 21.9%, up 220 bps YoY, with full-year EBITDA margin guided to 23.1%-23.5%. The weak point is cash generation, because FY25 free cash flow of $0.2B lags the earnings story and needs to improve materially for the full investment case to fully de-risk.

Competitive Position

XYL's moat comes from mission-critical water infrastructure, long asset lives, and customer reluctance to switch pumps, treatment systems, sensors, and network-management platforms once they are embedded in regulated utility operations. That moat is getting broader as the portfolio shifts from hardware toward connected sensing, analytics, and recurring digital tools, which raises switching costs and makes the installed base more valuable over time. The durability is not perfect, because project timing in metering can still swing results, but water quality and resilience regulation supports demand in a way few industrial end markets enjoy.

Management & Guidance

Management's current guidance is internally consistent and reasonably credible. The company now expects roughly $9.2B of FY26 revenue, 2%-3% organic growth, 23.1%-23.5% EBITDA margin, and $5.55-$5.70 EPS, explicitly stating that stronger first-half execution, buybacks, and margins offset metering delays. That matters because the team is not pretending revenue is stronger than it is, it is acknowledging the slowdown while still raising profit expectations. With 7 straight quarterly EPS beats and a Q3 EPS guide of $1.42-$1.47 after Q2 actual EPS of $1.46, the burden is now on management to show that cash flow and delayed deployments catch up to the income statement.

Segment Analysis

• Product segments (Not disclosed in the provided data): Current operating commentary points to pressure in MCS from deployment delays, while Applied Water is benefiting from data-center demand with Q2 orders up over 300%.
• MCS (Not disclosed in the provided data): FY26 outlook cut to low-single-digit revenue growth; EBITDA margin down 200 bps YoY on mix, inflation, and lower volume.
• Applied Water (Not disclosed in the provided data): Fastest incremental demand pocket in the call, helped by data centers; management said, "Data centers remain a very attractive growth area for us, and we expect our exposure to continue to increase over time."
• Geography, China (Not disclosed in the provided data): Q2 sales down 27% and orders down over 30%, the clearest geographic source of weakness.

Capital Allocation

Capital allocation is mixed but broadly disciplined. The company returned $0.8B in FY25 through $0.7B of buybacks and $0.1B of dividends, while capex was only $0.1B, preserving flexibility for portfolio moves like TriOS and WaterFleet. The weak spot is free cash flow, at only $0.2B in FY25, so buybacks currently look aggressive relative to cash generation and need to be backed by the promised low-double-digit FY26 free cash flow margin.

Management Execution & Track Record

Management's record since the 2024 Q3 call supports credibility. Back then, the company held FY24 EPS at $4.22-$4.24 and EBITDA margin at about 20.5% despite slightly lower revenue, while pointing to stronger synergies, backlog of $5.3B, and 80/20 benefits into 2025. Since then, FY25 delivered $9.0B of revenue, $3.93 EPS, and 12.2% operating margin, and by the 2026 Q2 call management had raised FY26 EPS to $5.55-$5.70 and EBITDA margin to 23.1%-23.5%, even after trimming organic growth because MCS deployments slipped. The key promise that delays were timing-related rather than demand destruction has held up reasonably well, with book-to-bill still above 1 and backlog still $5.3B, though not perfectly, because MCS remains weaker than hoped and China has deteriorated materially. On balance, seven straight quarterly EPS beats and margin delivery make this a credible team, but not an infallible one.

Positioning & Flows

Ownership is crowded institutionally, with the top three institutions at 85.0%, while insider ownership is only 0.2%, so the stock will trade on fundamentals more than on insider signaling. Short interest is modest at 3.45%, or 8.0M shares with 4 days-to-cover, which limits squeeze potential but also suggests the market is skeptical rather than aggressively bearish. Options positioning is less supportive near term, with a negative gamma regime and zero-gamma at $108.05, almost exactly spot, which can amplify moves around earnings rather than damp them.

Bull Case

• FY25 EPS grew 18.0% to $3.93 on only 2.4% revenue growth, showing that mix, productivity, and pricing are driving real earnings leverage.
• The stock trades at 25.63x FY25 EPS versus a 29.9x peer average P/E, and the quant engine's base value is $130.75, or 21.1% above the current $108.00.
• Management has beaten EPS estimates in 7 straight quarters through 2026-07-28, including beats of +11.4%, +9.6%, and +8.1%, which supports confidence in the raised FY26 EPS range.
• Balance-sheet risk is manageable at 1.71x debt/EBITDA and 0.29 debt/equity, giving XYL room to fund bolt-on deals like TriOS and WaterFleet while still repurchasing $0.7B of stock.

Bear Case

• FY26 organic revenue guidance was cut to 2%-3% from 2%-4%, and reported revenue is now only expected to be roughly $9.2B, a modest growth profile for an industrial growth story.
• China is a real drag, with Q2 sales down 27% and orders down over 30%, which creates risk that the weak geography remains a headwind into 2027.
• MCS is under pressure, with management cutting that business to low-single-digit revenue growth and citing 200 bps of EBITDA margin compression from mix, inflation, and lower volume.
• Cash conversion is the weakest part of the story right now, with FY25 free cash flow only $0.2B versus $0.7B of buybacks, so the equity story currently leans more on earnings quality than on reported cash generation.

Valuation & Price Target

Engine price target $130.75 (+21.1% vs current), Medium confidence.

• P/E Multiple: $113.02 (28% weight)
• P/S Multiple: $170.9 (20% weight)
• Quality-adjusted: $111.97 (20% weight)
• DCF: $138.65 (9% weight)

The quant baseline is HOLD, but the stock merits a BUY because the forward setup is better than the blended model likely captures. The engine's target is $130.75, already 21.1% above $108.00, and the market is valuing XYL at roughly 19x the midpoint of FY26 EPS guidance despite a raised earnings range, raised EBITDA margin guide, $5.3B backlog, and a balance sheet at only 1.71x debt/EBITDA. The reason not to follow the HOLD call is that the stock has de-rated hard, now 29.4% below its 52-week high and 12.0% below its 200-day average, while the business has not broken, it has simply slowed in specific pockets like China and metering. Sell-side consensus is Strong Buy from 5 buy / 2 hold / 0 sell, but that is low-signal context only and not the basis for the rating.

Risk Assessment

Risk score 45/100 (Moderate). The biggest risk is that MCS deployment delays and China weakness persist longer than management expects, leaving FY26 organic growth stuck at 2%-3% and preventing the earnings ramp implied by $5.55-$5.70 EPS guidance.

The Bottom Line

XYL rates a BUY, Medium conviction. The market has punished the stock for slower organic growth, but the evidence points to a business with rising earnings power, better margins, and stronger strategic positioning than the share price implies. The right lens is forward EPS of $5.55-$5.70, not trailing FY25 EPS of $3.93. A move toward the engine's $130.75 base value is reasonable if backlog converts and MCS delays stabilize. The rating would change if metering delays deepen into demand destruction, if China weakness spreads further, or if free cash flow fails to recover from the current $0.2B level.